Work

Integrative Analysis of the Genomic and Transcriptomic Landscape of Relapsed/Refractory Multiple Myeloma Patients Treated With Venetoclax in Combination With Bortezomib and Dexamethasone: Biomarker Analyses From the Phase 3 BELLINI Study

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-134710

Authors: Michael E. O'Dwyer, Andrew Spencer, Shaji K. Kumar, Rakesh Popat, Philippe Moreau, Monique Dail, Muhammad Jalaluddin, Xiaoqing Yang, Xin Lu, Zheng Zha, Fengjiao Dunbar, Deeksha Vishwamitra, Christine Mantis, Amal Melhem-Bertrandt, Jeremy A. Ross, Simon J Harrison

Institutions: Ollscoil na Gaillimhe – University of Galway, Monash University, Mayo Clinic, University College London Hospitals NHS Foundation Trust, University College London, Centre Hospitalier Universitaire de Nantes, Genentech, AbbVie (United States), The Royal Melbourne Hospital, Peter MacCallum Cancer Centre

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095846332

FWCI: 0.272

Cites:

Cited by: 3

Related to: 10